TNF and rheumatoid arthritis: Activation of monocytes from RA patients treated with infliximab was diminished compared to those before treatment, which may reflect suppression of monocytes by anti-TNFα leading to a reduction in IL-6 and IL-1β and suppression of Th17 cells.